268 related articles for article (PubMed ID: 24576884)
1. Human-induced pluripotent stem cell models of inherited cardiomyopathies.
Karakikes I; Termglinchan V; Wu JC
Curr Opin Cardiol; 2014 May; 29(3):214-9. PubMed ID: 24576884
[TBL] [Abstract][Full Text] [Related]
2. Untangling the Biology of Genetic Cardiomyopathies with Pluripotent Stem Cell Disease Models.
Buikema JW; Wu SM
Curr Cardiol Rep; 2017 Apr; 19(4):30. PubMed ID: 28315121
[TBL] [Abstract][Full Text] [Related]
3. Cardiomyopathy in a dish: using human inducible pluripotent stem cells to model inherited cardiomyopathies.
Kamdar F; Klaassen Kamdar A; Koyano-Nakagawa N; Garry MG; Garry DJ
J Card Fail; 2015 Sep; 21(9):761-70. PubMed ID: 25934595
[TBL] [Abstract][Full Text] [Related]
4. Human-induced pluripotent stem cells for modelling metabolic perturbations and impaired bioenergetics underlying cardiomyopathies.
Ramachandra CJA; Chua J; Cong S; Kp MMJ; Shim W; Wu JC; Hausenloy DJ
Cardiovasc Res; 2021 Feb; 117(3):694-711. PubMed ID: 32365198
[TBL] [Abstract][Full Text] [Related]
5. From Hypertrophy to Heart Failure: What Is New in Genetic Cardiomyopathies.
Reza N; Musunuru K; Owens AT
Curr Heart Fail Rep; 2019 Oct; 16(5):157-167. PubMed ID: 31243690
[TBL] [Abstract][Full Text] [Related]
6. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
[TBL] [Abstract][Full Text] [Related]
7. Maturation-Based Model of Arrhythmogenic Right Ventricular Dysplasia Using Patient-Specific Induced Pluripotent Stem Cells.
Wen JY; Wei CY; Shah K; Wong J; Wang C; Chen HS
Circ J; 2015; 79(7):1402-8. PubMed ID: 25971409
[TBL] [Abstract][Full Text] [Related]
8. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
9. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells.
Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW
J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cells in the inherited cardiomyopathies: From disease mechanisms to novel therapies.
Ross SB; Fraser ST; Semsarian C
Trends Cardiovasc Med; 2016 Nov; 26(8):663-672. PubMed ID: 27296521
[TBL] [Abstract][Full Text] [Related]
11. Electrical dysfunctions in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with an arrhythmogenic right ventricular cardiomyopathy.
El-Battrawy I; Zhao Z; Lan H; Cyganek L; Tombers C; Li X; Buljubasic F; Lang S; Tiburcy M; Zimmermann WH; Utikal J; Wieland T; Borggrefe M; Zhou XB; Akin I
Europace; 2018 Jun; 20(FI1):f46-f56. PubMed ID: 29566126
[TBL] [Abstract][Full Text] [Related]
12. [Genetics of inherited cardiomyopathies].
Richard P; Fressart V; Charron P; Hainque B
Pathol Biol (Paris); 2010 Oct; 58(5):343-52. PubMed ID: 19942368
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in animal and human pluripotent stem cell modeling of cardiac laminopathy.
Lee YK; Jiang Y; Ran XR; Lau YM; Ng KM; Lai WH; Siu CW; Tse HF
Stem Cell Res Ther; 2016 Sep; 7(1):139. PubMed ID: 27649756
[TBL] [Abstract][Full Text] [Related]
14. A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.
Davis J; Davis LC; Correll RN; Makarewich CA; Schwanekamp JA; Moussavi-Harami F; Wang D; York AJ; Wu H; Houser SR; Seidman CE; Seidman JG; Regnier M; Metzger JM; Wu JC; Molkentin JD
Cell; 2016 May; 165(5):1147-1159. PubMed ID: 27114035
[TBL] [Abstract][Full Text] [Related]
15. Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.
Kim C; Wong J; Wen J; Wang S; Wang C; Spiering S; Kan NG; Forcales S; Puri PL; Leone TC; Marine JE; Calkins H; Kelly DP; Judge DP; Chen HS
Nature; 2013 Feb; 494(7435):105-10. PubMed ID: 23354045
[TBL] [Abstract][Full Text] [Related]
16. Human Induced Pluripotent Stem-Cell-Derived Cardiomyocytes as Models for Genetic Cardiomyopathies.
Brodehl A; Ebbinghaus H; Deutsch MA; Gummert J; Gärtner A; Ratnavadivel S; Milting H
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31489928
[TBL] [Abstract][Full Text] [Related]
17. Modeling of human cardiomyopathy with induced pluripotent stem cells.
Lee YK; Ng KM; Tse HF
J Biomed Nanotechnol; 2014 Oct; 10(10):2562-85. PubMed ID: 25992409
[TBL] [Abstract][Full Text] [Related]
18. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
19. Human Induced Pluripotent Stem Cells for Inherited Cardiovascular Diseases Modeling.
Jiang W; Lan F; Zhang H
Curr Stem Cell Res Ther; 2016; 11(7):533-41. PubMed ID: 25322695
[TBL] [Abstract][Full Text] [Related]
20. Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy.
Sun N; Yazawa M; Liu J; Han L; Sanchez-Freire V; Abilez OJ; Navarrete EG; Hu S; Wang L; Lee A; Pavlovic A; Lin S; Chen R; Hajjar RJ; Snyder MP; Dolmetsch RE; Butte MJ; Ashley EA; Longaker MT; Robbins RC; Wu JC
Sci Transl Med; 2012 Apr; 4(130):130ra47. PubMed ID: 22517884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]